JAGU earnings analysis
What we found in JAGU's 10-Q: the parts that mattered, the offsets in the same document, and what the company said about what comes next.
Our reading of the filing · Free to read, no account needed
Jaguar Uranium reported Q2 2026 EPS of negative $0.04, better than the negative $0.06 consensus estimate, but revenue remained $0.00 and the filing provides no gross margin, operating margin, segment, or free-cash-flow detail. The company reported effective disclosure and internal controls as of June 30, 2026, with no material weaknesses, litigation, or previously unreported unregistered equity sales. Risk factors were unchanged from the December 31, 2025 Form 10-K, and no quantitative guidance was provided.
The parts that mattered.
Pulled out of the filing itself, with the figures the company reported.
- EPS Beat Consensus
- Reported EPS was negative $0.04 for Q2 2026 versus negative $0.06 consensus, a $0.02 favorable variance, or 33.3% better than the estimate.
- Disclosure Controls Effective
- Management concluded that disclosure controls and procedures were effective as of June 30, 2026, providing reasonable assurance that required information was reported within SEC time periods.
- No Material Control Weaknesses
- Management concluded that internal control over financial reporting was effective as of June 30, 2026, and identified no material weaknesses.
- No Material Litigation
- The company reported no material litigation, arbitration, or governmental proceeding pending against the company or its management as of the filing.
- No Unregistered Equity Sales
- No unregistered sales of equity securities occurred during the three months ended June 30, 2026 that had not been previously reported.
And the other side of it.
The offsets in the same document — the things a summary that only listed the good news would have left out.
- Existing Risks Remain Unchanged
- The filing states that there were no material changes from the risk factors in the December 31, 2025 Form 10-K, so the previously disclosed exploration, financing, regulatory, and operating risks remain applicable.
- No Revenue and Continuing Losses
- The company reported revenue of $0.00 and EPS of negative $0.04 for Q2 2026, indicating continued dependence on external capital while it advances its uranium projects.
- Inherent Control Limitations
- The filing states that internal controls have inherent limitations and that future evaluations may be affected by changing conditions or deterioration in compliance, despite controls being effective as of June 30, 2026.
What they reported.
What the company itself reported, taken out of the document.
- Earnings per share
- $-0.04
What they said about what is next.
The filing does not provide quantitative revenue or EPS guidance; no outlook, liquidity outlook, or capital-spending forecast was disclosed.
The filing reads worse than the one before it.
What came before.
- 10-Q · May 14, 2026
- Jaguar Uranium Corp. reported no revenue for the first quarter of 2026, with a net loss of $19.87M compared to a net loss of $513K in the same period last year. Operating expenses increased significantly to $1.42M,…
- 10-K · March 27, 2026
- Jaguar Uranium Corp. remains in the exploration stage with no operating revenues, having recorded a net loss of $2.31M in 2025, which is a reduction from $5.76M in 2024. The company raised $25M through its IPO in…
This is our reading of a public filing, not the filing. Read the original on SEC.gov · Educational only. Nothing here is investment advice.
Read the next one first.
We read every filing JAGU makes the day it lands, and put it next to what the options market did about it. Members get both, and an alert when a filing arrives.
Cancel anytime · Month to month · Switch tiers whenever